NCI vs LEVI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

NCI

48.4
AI Score
VS
LEVI Wins

LEVI

54.4
AI Score

Investment Advisor Scores

NCI

48score
Recommendation
HOLD

LEVI

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI LEVI Winner
Forward P/E 0 12.8041 Tie
PEG Ratio 1.13 0 Tie
Revenue Growth -50.8% 8.0% LEVI
Earnings Growth 34.0% 31.1% NCI
Tradestie Score 48.4/100 54.4/100 LEVI
Profit Margin 0.2% 9.7% LEVI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NCI 1M: +6.6% · 3M: +1081.1% LEVI 1M: +0.1% · 3M: +10.1%

Current Technical Phase

NCI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (61.0% over 20 days), RSI 71

RSI (14): 70.5 · Price: $12.39

LEVI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 52

RSI (14): 51.7 · Price: $24.52

Fundamentals Snapshot

Metric NCI LEVI
Market Cap
Forward P/E 0.0 14.4
Trailing P/E 150.8 18.1
Revenue (TTM)
Revenue Growth -0.5% 0.1%
Gross Margin 0.4% 0.6%
Operating Margin 0.0% 0.1%
EPS 0.08 1.36
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, LEVI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.